Oruka Therapeutics (ORKA) Shares Outstanding (Entity) (2009 - 2026)
Oruka Therapeutics (ORKA) recorded Shares Outstanding (Entity) of 62.87 million in Q2 2026, up 67.9% from 37.45 million a year earlier and up 14.0% from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Shares Outstanding (Entity) (2009 - 2026) Analysis & Trends
For FY2024, Oruka Therapeutics reported Shares Outstanding (Entity) of 16.89 million, up 117.6% from FY2023.
- Annual Shares Outstanding (Entity) has a five-year compound annual growth rate of 173.6% (FY2019 to FY2024).
- Across earlier years, Shares Outstanding (Entity) came in at 7.77 million in FY2023 (+546.7%), 1.2 million in FY2022 (unchanged), 1.2 million in FY2021 (+205.9%) and 392,504 in FY2020 (+256.5%).
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2010.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.0% (Q1 2022) and 546.7% (Q4 2023) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Oruka Therapeutics | 7.43 Bn | 4.55 Bn | - | 67.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 67.82 Mn |
| Jun 30, 2026 | 61.07 Mn |
| Mar 31, 2026 | 50.17 Mn |
| Dec 31, 2025 | 48.72 Mn |
| Sep 30, 2025 | 48.38 Mn |
| Jun 30, 2025 | 37.45 Mn |
| Mar 31, 2025 | 37.44 Mn |
| Dec 31, 2024 | 16.89 Mn |
| Sep 30, 2024 | 15.06 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 1.20 Mn |
API Access
Oruka Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();